Centre warns pharma cos against promoting weight loss drugs among public through ads.jpg

Centre warns pharma companies against promoting weight-loss drugs among public through ads

NEW DELHI: The Centre has warned pharmaceutical companies against promoting prescription weight-loss GLP-1 drugs – popularly sold under brand names Ozempic, Wegovy and Mounjaro – through advertisements or “disease awareness” campaigns that indirectly encourage their use among the public.In an advisory, Central Drugs Standard Control Organisation said it had come to its notice that some…

Read More
1773016053 unnamed file.jpg

FMCG and pharma emerge as new strongholds for women CEOs

NEW DELHI: There was a time when some of India’s leading banking and financial services firms had women at the helm, making these sectors a visible symbol of gender diversity. Today, that centre of gravity has shifted.Consumer-facing industries and pharmaceuticals have emerged as the new strongholds for women CEOs, reflecting where long-standing leadership pipelines are…

Read More
1772815663 unnamed file.jpg

As West Asia conflict rages on, India’s pharma exports stare at Rs 5K crore potential losses

Hyderabad: India’s pharmaceutical sector is staring at potential losses of Rs 2,500– Rs 5,000 crore if March exports to the Gulf Cooperation Council (GCC) and the wider West Asia and North Africa (WANA) are completely disrupted by the ongoing West Asia conflict, which is intensifying pressure on freight, shipping routes, and delivery schedules, according to…

Read More
1771690576 unnamed file.jpg

Pharma exports grow 9.4% to $30.47 billion in FY25; industry eyes double-digit expansion by 2026-27

India’s pharmaceutical exports rose 9.4 per cent in 2024–25 to $30.47 billion, with the industry targeting double-digit growth in 2026–27 amid efforts to expand global market access, the commerce ministry said on Saturday, PTI reported. Issues related to pharmaceutical exports were discussed during a Chintan Shivir held in Ahmedabad between government officials and industry representatives,…

Read More
1771689158 unnamed file.jpg

US tariff cut to 10% boosts outlook for India’s labour-intensive exports; pharma, textiles among key gainers

The reduction of US reciprocal tariffs on Indian goods from 25 per cent to 10 per cent is expected to significantly improve the competitiveness of labour-intensive sectors such as pharmaceuticals, electronics, engineering goods, textiles, and gems and jewellery in the American market, industry representatives said.The development follows a US Supreme Court ruling that struck down…

Read More
1771052293 unnamed file.jpg

India, Brazil likely to sign pharma, minerals and aviation pacts during Lula visit

PM Modi and Brazilian President Luiz Inacio Lula da Silva (File photo) Officials are finalising a set of India–Brazil agreements expected to be signed during Brazilian President Luiz Inacio Lula da Silva’s official visit to India next week, with the proposed pacts likely to boost pharmaceutical exports, strengthen cooperation in critical minerals and support the…

Read More
47529300.jpg

Pharma manufacturer Dadachanji forays into building med devices

NEW DELHI: The Dadachanji Group, which is focused on pharma manufacturing and allied technologies, has forayed into building fully customised machines, medical devices, and automation solutions in pharma, healthcare, and other sectors through KAIRISH Innotech. The company will offer end-to-end capabilities across customised pharma machinery, medical device design and manufacturing, tooling and precision components, robotics…

Read More
1770508510 unnamed file.jpg

India-US trade deal: Interim pact brings ‘certainty and clarity’ for pharma sector

NEW DELHI: The interim India-US trade arrangement provides certainty and clarity to the domestic pharma sector, with medicines staying outside reciprocal tariffs, and Washington signalling negotiated treatment for generics under Section 232.India plays a critical role in supplying affordable medicines to the US, with shipments of around $10 billion accounting for nearly 35% of its…

Read More
1770488118 unnamed file.jpg

India-US trade framework expected to deepen pharma and medtech collaboration, says IPA

The interim India-US trade agreement is expected to strengthen cooperation in pharmaceuticals and medical technology, with industry bodies saying medicine supply chains are closely linked to national security priorities.Strengthening the India-US medicines partnership is important as medicine security is a part of national security, the Indian Pharmaceutical Alliance said on Saturday, welcoming the interim trade…

Read More
Pharma1.jpg

Pharma companies await clarity, eye a dose of stability in India-US deal

NEW DELHI: Drug makers are set to gain clarity under the proposed India-US trade agreement, sharpening expansion plans in the world’s most lucrative pharmaceutical market. While the sector was insulated from punitive US tariffs, the generics business of major companies, including Sun Pharma, Dr Reddy’s and Cipla faced significant headwinds in the third quarter ended…

Read More